Glial cell response: A pathogenic factor in Parkinson's disease

被引:26
|
作者
Wu, DC
Tieu, K
Cohen, O
Choi, DK
Vila, M
Jackson-Lewis, V
Teismann, P
Przedborski, S
机构
[1] Columbia Univ, Dept Neurol, Movement Disorder Div, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, New York, NY USA
关键词
astrocyte; gliosis; IL-1; beta; iNOS; microglia; MPTP; neurodegeneration; Parkinson's disease;
D O I
10.1080/13550280290100905
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The loss of these neurons is associated with a glial response composed mainly of activated microglial cells and, to a lesser extent, of reactive astrocytes. This glial response may be the source of trophic factors and can protect against reactive oxygen species and glutamate. Alternatively, this glial response can also mediate a variety of deleterious events related to the production of pro-oxidant reactive species, proinflammatory prostaglandin, and cytokines. In this review, the authors discuss the potential protective and deleterious effects of glial cells in the SNpc of PD and examine how these factors; may contribute to the pathogenesis of this disease.
引用
收藏
页码:551 / 558
页数:8
相关论文
共 50 条
  • [41] Behavioral recovery in Parkinson's disease model by gene transfer of glial cell line-derived neurotrophic factor
    Zheng, JS
    Tang, LL
    Zhan, RY
    Zhou, YQ
    Chen, AF
    ANNALS OF NEUROLOGY, 2004, 56 : S11 - S11
  • [42] Regulation of Glial cell line-Derived Neurotrophic Factor (GDNF) for dopamine conservation in models for Parkinson's disease
    Ronken, E
    McCrossan, D
    Venema, J
    PARKINSON'S DISEASE, 2002, 1 : 148 - 156
  • [43] Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain
    Chauhan, NB
    Siegel, GJ
    Lee, JM
    JOURNAL OF CHEMICAL NEUROANATOMY, 2001, 21 (04) : 277 - 288
  • [45] Pathogenic Lysosomal Depletion in Parkinson's Disease
    Dehay, Benjamin
    Bove, Jordi
    Rodriguez-Muela, Natalia
    Perier, Celine
    Recasens, Ariadna
    Boya, Patricia
    Vila, Miquel
    JOURNAL OF NEUROSCIENCE, 2010, 30 (37): : 12535 - 12544
  • [46] Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
    Gill, SS
    Patel, NK
    Hotton, GR
    O'Sullivan, K
    McCarter, R
    Bunnage, M
    Brooks, DJ
    Svendsen, CN
    Heywood, P
    NATURE MEDICINE, 2003, 9 (05) : 589 - 595
  • [47] Is there a pathogenic role for mitochondria in Parkinson's disease?
    Vives-Bauza, Cristofol
    de Vries, Rosa L. A.
    Tocilescu, Maja Aleksandra
    Przedborski, Serge
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S241 - S244
  • [48] A Cortical Pathogenic Theory of Parkinson's Disease
    Foffani, Guglielmo
    Obeso, Jose A.
    NEURON, 2018, 99 (06) : 1116 - 1128
  • [49] Neutral (R)salsolinol N-methyltransferase as a pathogenic factor of Parkinson's disease
    Maruyama, W
    Yamada, T
    Washimi, Y
    Kachi, T
    Yanagisawa, N
    Ando, F
    Shimokata, H
    Naoi, M
    MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE, 2002, 51 : 277 - 280
  • [50] Long-Term Neuroprotection and Neurorestoration by Glial Cell-Derived Neurotrophic Factor Microspheres for the Treatment of Parkinson's Disease
    Garbayo, Elise
    Ansorena, Eduardo
    Luis Lanciego, Jose
    Jose Blanco-Prieto, Maria
    Aymerich, Maria S.
    MOVEMENT DISORDERS, 2011, 26 (10) : 1943 - 1947